ICICI Bank shares target price rise up to Rs 1,450 on steady Q4 results. Should you buy?

Shares of ICICI Bank on Monday rose over 2% to a fresh 52-week high of Rs 1,132.95 on BSE as brokerages raised the target prices with the highest one going up to Rs 1,450.

The private sector lender reported a healthy performance in Q4, with 17% year-on-year (YoY) growth in profit amid contained opex and provisions. The pace of NIM contraction decelerated, down 3 bps quarter-on-quarter (QoQ) at 4.4%.

Brokerages said ICICI Bank remains the preferred pick in the banking space, given its superior returns profile, top-management credibility, and strong capital/provision buffers.

Among global brokerages, CLSA raised the target price to Rs 1,350. JPMorgan, which has a target price of Rs 1,350 on ICICI Bank with an overweight rating, has upgraded F25/26 EPS estimate by 4% and said the valuations are reasonable and leave scope for upward re-rating.

Nomura has set a target price of Rs 1,335.

Emkay Global expects the bank to deliver higher RoA at 2.1-2.3%/RoE at 17-18% over FY25-26, mainly on the back of healthy margins/fees and lower LLP. The domestic brokerage has raised its target price from Rs 1,400 to Rs 1,450.Motilal Oswal has raised EPS estimates by 2% for FY26, with little change to the FY25 outlook. “We estimate RoA/RoE of 2.26%/18.0% in FY26. We expect the bank to sustain a ~14% CAGR in PAT over FY24-26E. Reiterate BUY with a revised SoTP-based target price of Rs 1,300,” it said.The bank’s management expects NIMs to remain range-bound even as they expect some deposit repricing accompanied by signs of easing competitive intensity on the lending side.”The bank has been generating RoAs higher than 2% despite margins being under pressure supported by healthy growth momentum. We believe ICICI Bank firmly remains on a path to delivering +2.3%/18.5% avg. RoA/ RoE over FY25-26E aided by asset quality being in good shape, and continued growth momentum while margins are expected to moderate slightly. ICICI bank has continued to deliver best-in-class return profile among its larger private peers which will help it retain its valuation premium,” said Sameer Bhise of JM Financial.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)

Source link

Denial of responsibility! NewsConcerns is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – [email protected]. The content will be deleted within 24 hours.

Leave a Comment